Enhanced monitoring of tenofovir-lamivudine-dolutegravir (TLD) replacing first-line HIV-antiretroviral treatment in Chiradzulu District, Malawi (EMEDT)

Principal investigator

Birgit Schramm
Purpose of study
Purpose of study

Study status

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline

Documents

Publications

No publications recorded
Previous study
Next study